Table 1 : Demographic and clinical characteristics of the cohort of 34 patients who had
MIB-1 digital quantification performed and who were suitable for survival analysis.


Characteristic DiffuseLarge
B-cell Lymphoma
Follicular Lymphoma Total

Number of Patients Gender
Male
Female
Relapse Status
Yes
No
Outcome
DOD
AWD
NED
18(53%)
9 (26%)
9 (26%)

10 (29%)
8(24%)

5(15%)
4(12%)
9(26%)
16(47%)*
6 (18%)
10(30%)

5(15%)
11(32%)

0
11(32%)
5(15%)
34(100%)
15(44%)
19(56%)

15(44%)
19(56%)

5(15%)
15(44%)
14(41%)

DLBCL=Diffuse Large B-Cell Lymphoma;  FL=Follicular Lymphoma; DOD: dead of disease;
AWD: alive with disease; NED: no evidence of disease
* Grade 1-2=14/16  (87.5%) , Grade 3=2/16  (12.5%)

Tchrakian et al.Journal of Histology & Histopathology  2018 5:3DOI : 10.7243/2055-091X-5-3